Articles

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial

Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milano
Hematology University Division, Verona
Hematology Division, Città della Salute Hospital, Torino
Hematology Division, Azienda Villa Sofia-Cervello, Palermo
Hematology Division, Papa Giovanni XXIII Hospital, Bergamo
Department of Cellular Biotechnologies and Hematology, La Sapienza University, Roma
Hematology Unit, La Maddalena Hospital, Palermo
SC Oncoematologia, Università degli Studi di Perugia
Hematology University Division, Ancona
Department of Hematology, S. Croce e Carle Hospital, Cuneo
Hematology University Division, Monza
Hematology Unit HSR, Milano
Oncologia Medica, Cancer Institute FPO, IRCCS, Candiolo
Hematology Division, Reggio Calabria
Hematology Univiversity Division, Catania
Division of Hematology, Brescia
University Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Hematology Division, S. Camillo Hospital, Roma
SC Ematologia AO SS Antonio e Biagio e Cesare Arrigo, Alessandria
Hematology University Division, Modena
Division of Oncology, Modena
Division of Internal Medicine, S. Luigi Hospital, Orbassano
Hematology University Division, Padova
Hematology Unit, Cremona
Hematology University Division, Bari
Hematology Division, Pescara
Hematology Division, Bolzano
Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milano
Hematology University Division, Città della Salute Hospital, Torino
Hematology Division, Papa Giovanni XXIII Hospital, Bergamo;Department of Oncology and Onco-Hematology, University of Milan, Milano
Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milano
University Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano;Department of Oncology and Onco-Hematology, University of Milan, Milano
Nuclear Medicine Division, Città della Salute Hospital, Torino
SC Ematologia AO SS Antonio e Biagio e Cesare Arrigo, Alessandria
Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milano;Department of Health Sciences, University of Milan, Milano, Italy
Vol. 104 No. 11 (2019): November, 2019 https://doi.org/10.3324/haematol.2018.209932